Anna B. is the Director of Quality- Analytical Molecule Drug Substance Stewardship at Eli Lilly and Company, where they provide GMP stewardship of the analytical control strategy for synthetic peptide drug substances. Previously, Anna served as a Senior Advisor and contributed significantly to regulatory inspection readiness and collaborative analytical strategies. Anna earned a Ph.D. in Chemistry from Penn State University, where they developed methods for identifying exogenous compounds in mammalian cells and published multiple peer-reviewed manuscripts. They also completed a Bachelor's degree in Chemistry at Juniata College, graduating cum laude.
This person is not in the org chart
This person is not in any teams
This person is not in any offices